Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2025 (Report No. 2)
Date of Filing: January 6, 2025
This filing serves to notify the SEC of a corporate event regarding regulatory compliance rather than providing periodic financial results. The Company is a foreign private issuer headquartered in Caesarea, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a notification of a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
Regulatory Status: The Company announced that it has regained full compliance with the Nasdaq Minimum Closing Bid Price Rule. This resolves a previous deficiency regarding the minimum bid price requirement for continued listing on the Nasdaq stock exchange.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.1) confirming the restoration of full Nasdaq compliance. No specific financial guidance, future outlook, or discussion of new risks is included in this document.
Unusual Items: The primary item of note is the successful resolution of the listing compliance issue.
Investor Verification Checklist
- Verify the current stock price to ensure it remains above the Nasdaq minimum closing bid price threshold.
- Review the full text of the press release (Exhibit 99.1) for any additional context on the compliance timeline.
- Check subsequent filings for the next scheduled financial report to assess the Company's operational and financial health, as this filing contains no financial data.